GlassScriptPhysician profile
Jason Wiechert
NPI 1235545971
$20,222.80
in general payments reported to CMS, 2019-2025
23 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,194 · 2021: $463 · 2022: $1,044 · 2023: $2,991 · 2024: $2,756 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,628 · Food and Beverage: $2,494 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,627.98 |
| Food and Beverage | $2,494.28 |
| Education | $248.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,086.89 | 2021-2025 | Inbone, Infinity, Prophecy |
| Elite Orthopedics, LLC | $4,719.83 | 2019-2020 | |
| Arthrex, INC. | $4,091.68 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $2,381.08 | 2019-2024 | Persona |
| Pinnacle, INC | $1,275.85 | 2019 | |
| Depuy Synthes Sales INC. | $592.62 | 2023-2025 | Attune |
| Medical Device Business Services, INC. | $269.98 | 2019 | |
| Smith+Nephew, INC. | $145.40 | 2025 | Evos |
| Janssen Pharmaceuticals, INC | $123.73 | 2021 | |
| Linvatec Corporation | $112.84 | 2024 | Biobrace 23mm |
| Osteoremedies, LLC | $91.34 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $77.75 | 2021 | |
| Pacira Therapeutics, INC. | $39.23 | 2021 | |
| Highridge Medical LLC | $38.22 | 2024-2025 | Biomet Ebi Bone Healing System |
| Heron Therapeutics, INC. | $34.96 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $23.60 | 2025 | Novosorb Btm |
| Treace Medical Concepts, INC. | $19.97 | 2024 | |
| Bioventus LLC | $19.82 | 2019 | |
| Urgo Medical North America, LLC | $18.12 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Amgen INC. | $17.54 | 2024 | Prolia, Evenity |
| Ebi, LLC | $14.74 | 2025 | Biomet Ebi Bone Healing System |
| Avanos Medical | $14.25 | 2025 | On-Q Pump and Accessories |
| Ferring Pharmaceuticals INC. | $13.36 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wiechert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.